Gerresheimer Future Growth
Future criteria checks 3/6
Gerresheimer is forecast to grow earnings and revenue by 19.7% and 9.4% per annum respectively. EPS is expected to grow by 19.6% per annum. Return on equity is forecast to be 12.8% in 3 years.
Key information
19.7%
Earnings growth rate
19.6%
EPS growth rate
Life Sciences earnings growth | 0% |
Revenue growth rate | 9.4% |
Future return on equity | 12.8% |
Analyst coverage | Good |
Last updated | 12 Mar 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
11/30/2026 | 2,636 | 239 | 110 | 457 | 8 |
11/30/2025 | 2,387 | 197 | 80 | 385 | 9 |
11/30/2024 | 2,134 | 146 | 15 | 334 | 9 |
11/30/2023 | 1,990 | 116 | -44 | 294 | N/A |
8/31/2023 | 1,974 | 107 | -24 | 287 | N/A |
5/31/2023 | 1,959 | 107 | -77 | 205 | N/A |
2/28/2023 | 1,904 | 97 | -86 | 171 | N/A |
11/30/2022 | 1,817 | 96 | -38 | 222 | N/A |
8/31/2022 | 1,725 | 91 | -45 | 214 | N/A |
5/31/2022 | 1,634 | 82 | -20 | 225 | N/A |
2/28/2022 | 1,566 | 85 | 4 | 238 | N/A |
11/30/2021 | 1,498 | 84 | 6 | 212 | N/A |
8/31/2021 | 1,465 | 86 | 1 | 203 | N/A |
5/31/2021 | 1,432 | 93 | -13 | 182 | N/A |
2/28/2021 | 1,418 | 94 | 62 | 243 | N/A |
11/30/2020 | 1,419 | 89 | 48 | 222 | N/A |
8/31/2020 | 1,385 | -25 | 53 | 235 | N/A |
5/31/2020 | 1,394 | -32 | 26 | 208 | N/A |
2/29/2020 | 1,388 | -14 | -16 | 165 | N/A |
11/30/2019 | 1,392 | 81 | 28 | 193 | N/A |
8/31/2019 | 1,415 | 207 | 2 | 161 | N/A |
5/31/2019 | 1,410 | 207 | 48 | 183 | N/A |
2/28/2019 | 1,386 | 179 | 38 | 159 | N/A |
11/30/2018 | 1,368 | 129 | 59 | 173 | N/A |
8/31/2018 | 1,351 | 124 | 87 | 184 | N/A |
5/31/2018 | 1,329 | 131 | 85 | 192 | N/A |
2/28/2018 | 1,336 | 137 | 94 | 206 | N/A |
11/30/2017 | 1,348 | 101 | 103 | 219 | N/A |
8/31/2017 | 1,331 | 49 | N/A | 184 | N/A |
5/31/2017 | 1,350 | 53 | N/A | 176 | N/A |
2/28/2017 | 1,358 | 56 | N/A | 190 | N/A |
11/30/2016 | 1,375 | 58 | N/A | 173 | N/A |
8/31/2016 | 1,299 | 118 | N/A | 195 | N/A |
5/31/2016 | 1,292 | 106 | N/A | 201 | N/A |
2/29/2016 | 1,301 | 99 | N/A | 188 | N/A |
11/30/2015 | 1,283 | 96 | N/A | 204 | N/A |
8/31/2015 | 1,335 | 69 | N/A | 206 | N/A |
5/31/2015 | 1,315 | 69 | N/A | 173 | N/A |
2/28/2015 | 1,294 | 68 | N/A | 165 | N/A |
11/30/2014 | 1,290 | 66 | N/A | 158 | N/A |
8/31/2014 | 1,282 | 71 | N/A | 146 | N/A |
5/31/2014 | 1,275 | 71 | N/A | 135 | N/A |
2/28/2014 | 1,267 | 63 | N/A | 149 | N/A |
11/30/2013 | 1,266 | 62 | N/A | 147 | N/A |
8/31/2013 | 1,266 | 64 | N/A | 156 | N/A |
5/31/2013 | 1,260 | 59 | N/A | 169 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GXI N's forecast earnings growth (19.7% per year) is above the savings rate (7.7%).
Earnings vs Market: GXI N's earnings (19.7% per year) are forecast to grow faster than the MX market (10.1% per year).
High Growth Earnings: GXI N's earnings are forecast to grow, but not significantly.
Revenue vs Market: GXI N's revenue (9.4% per year) is forecast to grow faster than the MX market (6.8% per year).
High Growth Revenue: GXI N's revenue (9.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GXI N's Return on Equity is forecast to be low in 3 years time (12.8%).